Group UCSW. United States Cancer Statistics Data Visualizations Tool. Retrieved 5 January 2024 at https://gis.cdc.gov/Cancer/USCS/#/AtAGlance/.

Yang WJ, Zhao HP, Yu Y, et al. Updates on global epidemiology, risk, and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29:2452–68. https://doi.org/10.3748/wjg.v29.i16.2452.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Foster JM, Zhang C, Rehman S, Sharma P, Alexander HR. The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future. CA Cancer J Clin. 2023;73:49–71. https://doi.org/10.3322/caac.21749.

Article  PubMed  Google Scholar 

Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival, and risk factors. Int J Cancer. 2014;134:622–8. https://doi.org/10.1002/ijc.28373.

Article  CAS  PubMed  Google Scholar 

Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol. 2017;10:149. https://doi.org/10.1186/s13045-017-0517-9.

Article  PubMed  PubMed Central  Google Scholar 

Burke EC, Karpeh MS, Conlon KC, Brennan MF. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997;225:262–7. https://doi.org/10.1097/00000658-199703000-00004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coccolini F, Cotte E, Glehen O, et al. Intraperitoneal chemotherapy in advanced gastric cancer: meta-analysis of randomized trials. EJSO Eur J Surg Oncol. 2014;40:12–26. https://doi.org/10.1016/j.ejso.2013.10.019.

Article  CAS  PubMed  Google Scholar 

Yonemura Y, Elnemr A, Endou Y, et al. Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer. Int J Surg Oncol. 2012;2012:148420. https://doi.org/10.1155/2012/148420.

Article  PubMed  PubMed Central  Google Scholar 

Ajani JA, Ota DM, Jessup JM, et al. Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy. Cancer. 1991;68:1501–6. https://doi.org/10.1002/1097-0142(19911001)68:7%3c1501::aid-cncr2820680706%3e3.0.co;2-l.

Article  CAS  PubMed  Google Scholar 

Network NCC. Gastric Cancer (v.2.2023). Updated 29 August 2023. Retrieved 5 January 2024 at https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.

Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33:1005–20. https://doi.org/10.1016/j.annonc.2022.07.004.

Article  CAS  PubMed  Google Scholar 

Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17:309–18. https://doi.org/10.1016/s1470-2045(15)00553-7.

Article  CAS  PubMed  Google Scholar 

Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358–63. https://doi.org/10.1002/(sici)1097-0142(20000115)88:2%3c358::aid-cncr16%3e3.0.co;2-o.

Article  CAS  PubMed  Google Scholar 

Boerner T, Graichen A, Jeiter T, et al. CRS-HIPEC prolongs survival but is not curative for patients with peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol. 2016;23:3972–7. https://doi.org/10.1245/s10434-016-5306-0.

Article  CAS  PubMed  Google Scholar 

Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702–13. https://doi.org/10.1245/s10434-007-9487-4.

Article  PubMed  Google Scholar 

Santullo F, Ferracci F, Abatini C, et al. Gastric cancer with peritoneal metastases: a single-center outline and comparison of different surgical and intraperitoneal treatments. Langenbecks Arch Surg. 2023;408:437. https://doi.org/10.1007/s00423-023-03163-1.

Article  PubMed  Google Scholar 

Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:2370–7. https://doi.org/10.1245/s10434-010-1039-7.

Article  PubMed  Google Scholar 

Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116:5608–18. https://doi.org/10.1002/cncr.25356.

Article  PubMed  Google Scholar 

Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37:2028–40. https://doi.org/10.1200/jco.18.01688.

Article  CAS  PubMed  Google Scholar 

Marano L, Marrelli D, Sammartino P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with synchronous peritoneal metastases: multicenter study of “Italian peritoneal surface malignancies oncoteam-S.I.C.O.” Ann Surg Oncol. 2021;28:9060–70. https://doi.org/10.1245/s10434-021-10157-0.

Article  PubMed  PubMed Central  Google Scholar 

Akturk Esen S, Ozgun YM, Hasturk D, et al. Neoadjuvant chemotherapy followed by cytoreductive surgery and HIPEC improves survival in peritoneal metastatic gastric cancer. Oncology. 2023;101:321–7. https://doi.org/10.1159/000528609.

Article  CAS  PubMed  Google Scholar 

Rau B, Lang H, Koenigsrainer A, et al. Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial. J Clin Oncol. 2024;42:146–56. https://doi.org/10.1200/jco.22.02867.

Article  CAS  PubMed  Google Scholar 

Ikoma N, Chen HC, Wang X, et al. Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol. 2017;24:2679–87. https://doi.org/10.1245/s10434-017-5838-y.

Article  PubMed  Google Scholar 

Jian C, Mou H, Zhang Y, Fan Q, Ou Y. Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: a meta-analysis of randomized controlled trials. Front Pharmacol. 2023;14:1094834. https://doi.org/10.3389/fphar.2023.1094834.

Article  PubMed  PubMed Central  Google Scholar 

Hotopp T. HIPEC and CRS in peritoneal metastatic gastric cancer: Who really benefits? Surg Oncol. 2019;28:159–66. https://doi.org/10.1016/j.suronc.2019.01.005.

Article  PubMed  Google Scholar 

Manzanedo I, Pereira F, Rihuete Caro C, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish group of peritoneal oncologic surgery (GECOP). Ann Surg Oncol. 2019;26:2615–21. https://doi.org/10.1245/s10434-019-07450-4.

Article  PubMed  Google Scholar 

Bonnot PE, Lintis A, Mercier F, et al. Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study). Br J Surg. 2021;108:1225–35. https://doi.org/10.1093/bjs/znab200.

Article  CAS  PubMed  Google Scholar 

Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575–81. https://doi.org/10.1245/s10434-011-1631-5.

Article  PubMed  PubMed Central  Google Scholar 

Sun J, Song Y, Wang Z, et al. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer. 2012;12:526. https://doi.org/10.1186/1471-2407-12-526.